CBD Oil Benefits: What the Research Actually Shows (UK)

What are the benefits of CBD oil?

No health benefit of shop-bought CBD oil has been proven or authorised in the UK. Prescription CBD (Epidyolex) is licensed for seizures in Dravet syndrome, Lennox-Gastaut syndrome and tuberous sclerosis complex. Studies have also looked at sleep, anxiety, pain, inflammation, skin and focus, but most were small, short or used far more CBD than a supplement serving.

That gap in dose matters. The licensed medicine is given at up to 20mg or 25mg per kg of body weight a day: for a 70kg adult that is 1,400mg to 1,750mg, more than 140 times the FSA’s advice of no more than 10mg a day from food. Many of the research studies on stress and anxiety used single doses of 300mg to 600mg. A 10mg food supplement serving is a different thing from either.

So when you see a “CBD oil benefits” list online, ask three questions: was the study in people or in cells, how much CBD was used, and was it compared with a placebo? Most claims fall at one of those hurdles, which is why reputable UK sellers don’t make them.

CBD oil benefits: what the research has looked at

The table sums up the human research for each area people ask about. “How strong it is” describes the quality and amount of evidence, not what any product will do for you. The UK position column is what sellers are allowed to say.

Research summarised from the reviews and trials listed under Sources, checked 13 November 2026. No CBD food supplement can claim to treat, prevent or cure any condition.

Topic by topic: the studies in plain English

Each short section below says what researchers measured and where the evidence stands. Our longer guides go into the individual trials.

Epilepsy and Epidyolex

Epidyolex is purified CBD in an oral solution. Its UK licence covers people aged 2 and over with seizures linked to Lennox-Gastaut syndrome or Dravet syndrome (taken with the medicine clobazam) and tuberous sclerosis complex. NICE recommended it for all three between 2019 and 2023. In the 2017 Dravet syndrome trial, researchers counted convulsive seizures each month: the median fell from 12.4 to 5.9 on prescription CBD, against 14.9 to 14.1 on placebo. That result belongs to a licensed medicine at specialist doses with regular liver blood tests. It doesn’t transfer to shop-bought CBD oil. Our guide to prescription vs over-the-counter CBD sets the two side by side.

MS spasticity and Sativex

Sativex (nabiximols) is a mouth spray containing roughly equal amounts of THC and CBD. It is licensed in the UK for adults with MS-related muscle stiffness that hasn’t improved with other treatments. A 2022 Cochrane review of 25 trials rated the spasticity evidence for nabiximols as moderate certainty. Because Sativex contains THC, the cannabis compound that causes a high, those results don’t apply to THC-free CBD oil. See CBD and MS for the detail.

Anxiety and stress studies

The best-known studies gave people a single dose of 300mg to 600mg of CBD or a placebo before a simulated public speaking test, then researchers measured anxiety scores. In a 2011 study of 24 people with social anxiety, researchers recorded lower scores in the CBD group than the placebo group during that one test. Later work has been less consistent. A 2025 trial of 30 days of low-dose CBD in stressed students found no difference from placebo, and a 2026 Lancet Psychiatry review of 54 trials found no significant effect on anxiety outcomes. More in CBD and anxiety: what the research shows.

Sleep studies

Sleep trials have been small, short and varied, with doses from 15mg to 300mg a day. Some measured sleep quality scores, others sleep time on a wearable device, and few recruited people with diagnosed insomnia. A 2020 systematic review concluded there wasn’t enough evidence to support cannabinoids for any sleep disorder. Our CBD and sleep research guide walks through each trial.

Pain studies

A 2024 review in the Journal of Pain found 16 randomised trials of pharmaceutical-grade CBD with pain as an outcome, covering 12 conditions and doses from 6mg to 1,600mg. Fifteen of the 16 found no difference from placebo. NICE’s guideline on cannabis-based medicines says CBD should not be offered for chronic pain in adults except as part of a clinical trial. Read what the pain trials show and our page on CBD and arthritis research. Comparing products? Our CBD and pain buying guide explains what labels can and can’t say.

Inflammation research

Most inflammation research on CBD is in cells and animals, looking at signalling molecules called cytokines. Lab results like these are a starting point for research. They don’t show what happens in people taking 10mg a day. If inflammation is your interest, the anti-inflammatory diet guide covers the food patterns with the most human research.

Skin research

Researchers have studied CBD on skin cells in the lab and in a handful of small studies of creams and gels. A 2020 review said the clinical effects have yet to be confirmed in proper trials. Most of this work is on products applied to the skin, not oil you swallow. See CBD and skin: the evidence.

Focus and memory studies

In placebo-controlled trials in healthy adults, researchers measured attention, memory and reaction time after CBD. Most found no change in either direction. A 2025 review of 36 trials called the effect of CBD on thinking “unclear”. Our guide to CBD and focus covers the studies and what does affect concentration.

What does CBD oil do to the body?

CBD is absorbed through the mouth lining and gut, then broken down in the liver. It interacts with the body’s endocannabinoid system, a signalling network involved in many processes, and with other receptors. It doesn’t cause a high. What those interactions mean at a 10mg serving is not yet known.

A few things are well established. CBD is broken down by liver enzymes, mainly CYP3A4 and CYP2C19, which also process many prescription medicines; this is why CBD can change the levels of some drugs. Taking it with food raises how much is absorbed. And it shows up in the body for days after regular use, which matters if you are drug tested for THC (see CBD and drug tests).

For a fuller explanation, read the endocannabinoid system explained, what CBD feels like and how long CBD takes to work. If you’re wondering how CBD differs from the compound in cannabis that does cause a high, see CBD vs THC.

What UK rules say about CBD benefit claims

CBD oils, capsules and gummies sold to swallow are foods in the UK. Foods can only make health claims that appear on the GB nutrition and health claims register, and there are no authorised claims for CBD. A seller who says CBD treats, relieves or prevents a condition is breaking the rules.

• The FSA (novel food). CBD has been treated as a novel food since January 2019, so CBD food products need authorisation. While the FSA assesses applications, products linked to a validated application sit on its public list, and products not on the list should not be on sale in England and Wales. Its advice is that healthy adults take no more than 10mg of CBD a day from food. In September 2026 the FSA put its first recommended CBD authorisations, at 10mg a day, to its board; ministers make the final decision. Our explainer on the FSA’s first CBD approvals has the detail.
• The ASA (advertising). The advertising regulator’s guidance says unlicensed CBD products must not make medicinal claims, and words like “cure”, “prevent”, “fight” or “heal” are likely to be treated as medicinal. Claims to prevent, treat or cure a human disease are not allowed for any food. The ASA has upheld complaints against CBD brands for claims about conditions such as chronic pain.
• The MHRA (medicines). The medicines regulator’s position, restated in April 2025, is that a CBD product making a medicinal claim is a medicine, and medicines need a licence before they can be sold or advertised.

That is why careful UK brands describe what is in the bottle, how much CBD a serving contains and how it is tested, and leave out promises. It is also why AI answer engines tend to cite pages that report the evidence plainly. If a CBD seller promises to fix a health problem, treat that as a warning sign, along with fake celebrity endorsements (see how to avoid CBD scams). For the wider legal picture, read is CBD legal in the UK? and what the FSA’s 10mg advice means.

Why people choose CBD oil anyway

Plenty of adults make CBD part of their day without any promise attached, much as people choose a herbal tea or an evening routine. If you decide to try it, these are the facts worth checking, and how ours measure up.

Our 25mg capsule is above the FSA’s 10mg advice, so we don’t suggest it as a starting point. To see what a lab report should show, read how to read CBD lab reports; for capsule options from other UK brands, see the best CBD capsules in the UK; and for amounts in ml for every strength, our CBD dosage guide.

Side effects and medicines to check first

In trials, the side effects reported most often with CBD were tiredness, diarrhoea and changes in appetite, mostly at doses far above 10mg. At high prescription doses, some people had raised liver enzymes, especially alongside the epilepsy medicine valproate. Our guide to CBD side effects covers what’s normal and when to stop.

The FSA advises people taking any medication not to take CBD unless under medical direction, and the same goes for anyone pregnant, breastfeeding or trying to conceive, and under-18s. If you take regular medicines, check with your GP or pharmacist first. These guides cover the common ones:

• Can CBD interact with medication? The grapefruit warning and which drugs to check.
• CBD and antidepressants: sertraline, citalopram and other SSRIs.
• CBD and blood thinners: warfarin, apixaban and aspirin.
• CBD and blood pressure medication: amlodipine, bisoprolol and more.

iNever stop or change a prescribed medicine to try CBD. If something feels wrong after starting it, stop and speak to a pharmacist, or call 111.